This paper deals with a new product, Timolol Maleate (Timoptol), for the treatment. of open angle glaucoma. A study of its therapeutic merits as compared with other drugs in common use for the treatment of glaucoma is evaluated. It is well suited for patients with intra-ocular pressure (IOP) of less than 33 mm Hg.